Andrew Pollard, director of Oxford University's research team, 선릉셔츠룸 which is co-developing the Corona 19 vaccine with AstraZeneca, said in an interview with BBC Radio on the 19th (local time) that "the results of a positive three-phase clinical trial will be announced before Christmas."
SK Bioscience, a Korean pharmaceutical company that signed a letter of intent (LOI) with AstraZeneca in July, 분당셔츠룸 is also drawing attention. In July, SK Bioscience signed a three-way cooperation letter (LOI) with AstraZeneca and the Ministry of Health and Welfare for the domestic and global supply of Corona 19 vaccine candidate substance "AZD1222."
The LOI includes SK Bioscience's participation in manufacturing the Corona 19 vaccine, while the Ministry of Health and Welfare supports the two companies' 수원셔츠룸 cooperation in producing and exporting vaccines to be implemented quickly.